Pharma Fusion Acquires Chicago's Columbia Pharmacy

Acquisition expands national specialty pharmacy network and enhances patient support services

Apr. 7, 2026 at 1:08pm

Got story updates? Submit your updates here. ›

A photorealistic studio still-life featuring a stack of prescription medication bottles, a syringe, and a stethoscope arranged elegantly on a clean, white background, conveying the precision and care of specialty pharmacy services.A new era of specialty pharmacy services combines advanced technology and personalized patient care.Lake Charles Today

Pharma Fusion, a leading national specialty pharmacy organization, has announced the acquisition of Columbia Pharmacy, a respected Chicago-based specialty and 340B pharmacy provider. The transaction marks a significant milestone in Pharma Fusion's growth, expanding its clinical footprint and elevating specialized services for patients living with complex, rare, and chronic conditions across the United States.

Why it matters

The acquisition combines Pharma Fusion's advanced operational scale, national reach, and proprietary technology with Columbia Pharmacy's decades of niche clinical experience. This will create a more powerful and connected specialty ecosystem designed to remove barriers to quality care, increase patient compliance, and improve real-world outcomes for patients, providers, and payers.

The details

Through this acquisition, Columbia Pharmacy will gain access to Pharma Fusion's proprietary, AI-driven health score statistics and data infrastructure, which delivers actionable insights into patient outcomes, adherence patterns, and prescribing behaviors. This will help provide comprehensive therapeutic choices and support more efficient use of healthcare resources.

  • Pharma Fusion announced the acquisition on April 7, 2026.
  • The acquisition is expected to extend Pharma Fusion's revenues to over $150 million for 2026.

The players

Pharma Fusion

A leading national specialty pharmacy organization dedicated to improving outcomes for patients living with rare and complex conditions.

Columbia Pharmacy

A respected Chicago-based specialty and 340B pharmacy provider known for its dedicated focus on patient health, local access, and community-based clinical support.

Dr. Sajal Roy

The Chairman of the Board of Pharma Fusion.

Got photos? Submit your photos here. ›

What they’re saying

“The acquisition of Columbia Pharmacy is a strategic fit that aligns perfectly with our Specialty Intelligence™ model. Columbia's reputation for clinical excellence complements our goal of removing geographic and administrative barriers for patients who require sophisticated, personalized care.”

— Dr. Sajal Roy, Chairman of the Board, Pharma Fusion

What’s next

The acquisition is expected to enable Pharma Fusion to serve patients across all 50 U.S. states and multiple U.S. territories, representing a fully scaled specialty platform with the capacity to grow, innovate, and respond rapidly to evolving healthcare needs.

The takeaway

This acquisition strengthens Pharma Fusion's national specialty pharmacy network and enhances its ability to provide personalized, high-touch patient care and support services for those living with complex, rare, and chronic conditions.